Shares of Laboratory Corp LH moved higher by 2.0% in pre-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share rose 269.23% year over year to $10.56, which beat the estimate of $8.11.
Revenue of $4,490,000,000 rose by 52.05% year over year, which beat the estimate of $3,950,000,000.
Outlook
Laboratory Corp hasn't issued any earnings guidance for the time being.
Laboratory Corp hasn't issued any revenue guidance for the time being.
Conference Call Details
Date: Feb 11, 2021
Time: 09:00 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/7kic6pr8
Technicals
Company's 52-week high was at $237.88
52-week low: $98.02
Price action over last quarter: Up 14.71%
Company Description
Laboratory Corporation of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.